We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Download a PDF for this medicationLevothyroxine sodium 50microgram 1 tablet
Levothyroxine belongs to a group of medicines called thyroid hormones, which are used to treat underactive thyroid gland. Levothyroxine contains the active ingredient levothyroxine sodium which is the same as thyroxine, a hormone produced by the thyroid gland.
They tablets are taken to replace the thyroxine that is normally naturally produced by the thyroid gland.
Levothyroxine is a replacement for a hormone normally produced by your thyroid gland to regulate the body's energy and metabolism.
Levothyroxine is given when the thyroid does not produce enough of this hormone on its own.
Levothyroxine is given when the thyroid does not produce enough of this hormone on its own.
Adrenal insufficiency - Patients with panhypopituitarism or other causes predisposing to adrenal insufficiency may react unfavourably to levothyroxine treatment, and it is advisable to initiate corticosteroid therapy before giving levothyroxine sodium in these cases.
Cardiac problems - Special care is needed in patients with symptoms of myocardial insufficiency or ECG evidence of myocardial infarction or ischaemia.
Diabetes - Special care is needed in patients with diabetes mellitus or insipidus. Levothyroxine raises blood sugar levels and this may upset the stability of patients receiving antidiabetic agents.
Patients should be monitored carefully to ensure the correct dose is prescribed.
Potential for bone loss - Subclinical hyperthyroidism may be associated with bone loss. To minimise the risk of osteoporosis, dosage of levothyroxine should be titrated to the lowest possible effective level.
Elderly - Special care is needed in the elderly.
Children - Parents of children receiving levothyroxine should be advised that partial loss of hair may occur during the first few months of therapy, but this effect is usually transient and subsequent regrowth usually occurs.
Use in pregnancy:
Levothyroxine has been taken by a large number of pregnant women and women of childbearing age without any form of definite disturbances in the reproductive process having been observed so far. Thyroid hypo- or hyperactivity in the mother may, however, unfavourably influence the fetal outcome or well-being.
Use in lactation:
Levothyroxine is excreted in breast milk in low concentrations and this may be sufficient to interfere with neonatal screening for hypothroidism.
Effects on ability to drive and use machines:
From the pharmacokinetic and pharmacodynamic properties of levothyroxine, treatment with levothyroxine would not be expected to interfere with ability to drive or operate machinery.
Cardiac problems - Special care is needed in patients with symptoms of myocardial insufficiency or ECG evidence of myocardial infarction or ischaemia.
Diabetes - Special care is needed in patients with diabetes mellitus or insipidus. Levothyroxine raises blood sugar levels and this may upset the stability of patients receiving antidiabetic agents.
Patients should be monitored carefully to ensure the correct dose is prescribed.
Potential for bone loss - Subclinical hyperthyroidism may be associated with bone loss. To minimise the risk of osteoporosis, dosage of levothyroxine should be titrated to the lowest possible effective level.
Elderly - Special care is needed in the elderly.
Children - Parents of children receiving levothyroxine should be advised that partial loss of hair may occur during the first few months of therapy, but this effect is usually transient and subsequent regrowth usually occurs.
Use in pregnancy:
Levothyroxine has been taken by a large number of pregnant women and women of childbearing age without any form of definite disturbances in the reproductive process having been observed so far. Thyroid hypo- or hyperactivity in the mother may, however, unfavourably influence the fetal outcome or well-being.
Use in lactation:
Levothyroxine is excreted in breast milk in low concentrations and this may be sufficient to interfere with neonatal screening for hypothroidism.
Effects on ability to drive and use machines:
From the pharmacokinetic and pharmacodynamic properties of levothyroxine, treatment with levothyroxine would not be expected to interfere with ability to drive or operate machinery.
Unless instructed differently, take your tablets with a glass of water,
preferably before breakfast. The tablets must be swallowed whole.
Keep out of the reach and sight of children.
Do not take this medicine if the expiry date on the label has passed.
The expiry date refers to the last day of that month.
Levothyroxine Tablets should not be taken if they show signs of deterioration such as discoloration.
Do not store above 25°C.
Store in the original container or package in order to protect from light and moisture. Do not transfer the tablets to another container.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
Keep out of the reach and sight of children.
Do not take this medicine if the expiry date on the label has passed.
The expiry date refers to the last day of that month.
Levothyroxine Tablets should not be taken if they show signs of deterioration such as discoloration.
Do not store above 25°C.
Store in the original container or package in order to protect from light and moisture. Do not transfer the tablets to another container.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
Availability: In stock
SKU
Levo50